Amanote Research

Amanote Research

    RegisterSign In

New PrEP Formulation Approved…but Only for Some

The Lancet HIV - United Kingdom
doi 10.1016/s2352-3018(19)30350-9
Full Text
Open PDF
Abstract

Available in full text

Categories
EpidemiologyInfectious DiseasesImmunologyVirology
Date

November 1, 2019

Authors

Unknown

Publisher

Elsevier BV


Related search

PrEP Works, but Only When You [Have Access To] Take It: Improving PrEP Access for Young People in Chicago and Philadelphia

International Journal of Virology and AIDS
2016English

Avastin Approved for Some Cervical Cancers

Cancer Discovery
Oncology
2014English

Enasidenib Approved for AML, but Best Uses Unclear

Cancer Discovery
Oncology
2017English

HIV Pre-Exposure Prophylaxis (PrEP): Effective but Controversial

Trends in Urology & Men's Health
2017English

The Socio-Technical Connection Is Plastic, but Only When Design Starts From Need Formulation

English

New & Approved: New Approvals, Indications, Formulations

Pharmacy Today
2018English

Current Concepts for PrEP Adherence in the PrEP Revolution

Current Opinion in HIV and AIDS
VirologyOncologyInfectious DiseasesImmunologyHematology
2016English

Some Guppies Only Have Eyes for Orange

Journal of Experimental Biology
EvolutionEcologyInsect ScienceMolecular BiologySystematicsAnimal ScienceMedicineAquatic ScienceBehaviorZoologyPhysiology
2019English

Success Coming — But Only Slowly

Nature
Multidisciplinary
1990English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy